How many insider declarations has Renaud, Philip filed?

Renaud, Philip has filed 4 public insider declarations with SEDI.

What is Renaud, Philip's role?

Renaud, Philip's reported role is not specified by the regulator across the filings.

Which companies does Renaud, Philip report trades for?

Renaud, Philip reports trades for Kane Biotech Inc..

What is Renaud, Philip's declared buy vs sell volume?

Across the available history, declared buys total 622k€ and disposals 0.

← Executives ★ Sign in to follow

RP

Renaud, Philip

OFFICER

·SEDI

Kane Biotech Inc.

0

申报总数

0

公司

€621,900

▲ 买入（2 笔）

—

▼ 卖出（0 笔）

Browse the complete record of transactions filed by Renaud, Philip. Insider active across 1 company, notably Kane Biotech Inc.. Aggregated, 4 disclosures have been published. Split: 2 buys · 0 sell. Total volume traded: €622k. Activity tracked since 25 May 2026. The latest transaction was disclosed on 25 May 2026 (53 - Grant of warrants). Regulator: SEDI. All data is openly available.

Companies and markets linked to Renaud, Philip

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Kane Biotech Inc. (CA)

申报4 总计

▲

Renaud, Philip

4 - Director of Issuer高管2025年6月26日Kane Biotech Inc.

11SEDI ↗

@ €0.0627Convertible DebenturesTSXSEDI:4724819

标准退出：2025年9月24日 (T+90)

●

Renaud, Philip

4 - Director of Issuer高管2010年9月15日Kane Biotech Inc.

11SEDI ↗

Convertible DebenturesTSXSEDI:4724814

●

Renaud, Philip

4 - Director of Issuer高管2026年5月25日Kane Biotech Inc.

CA$120万16SEDI ↗

20,000,000 股@ CA$0.0654.5% 占其流量WarrantsTSXSEDI:4724813

▲

Renaud, Philip

4 - Director of Issuer高管2026年5月25日Kane Biotech Inc.

CA$100万16SEDI ↗

20,000,000 股@ CA$0.0545.5% 占其流量Common SharesTSXSEDI:4724810

标准退出：2026年8月23日 (T+90)

4 条申报中的 4 条

InsidersTradesSigma

← Executives ★ Sign in to follow

RP

Renaud, Philip

OFFICER

·SEDI

Kane Biotech Inc.

0

申报总数

0

公司

€621,900

▲ 买入（2 笔）

—

▼ 卖出（0 笔）

Browse the complete record of transactions filed by Renaud, Philip. Insider active across 1 company, notably Kane Biotech Inc.. Aggregated, 4 disclosures have been published. Split: 2 buys · 0 sell. Total volume traded: €622k. Activity tracked since 25 May 2026. The latest transaction was disclosed on 25 May 2026 (53 - Grant of warrants). Regulator: SEDI. All data is openly available.